CARNA BIOSCIENCES

carna-biosciences-logo

Carna Biosciences discover and develop significant medical values that will provide therapeutic solutions for improving human health.

#SimilarOrganizations #People #Financial #Website #More

CARNA BIOSCIENCES

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2003-04-10

Address:
Chuo, Hokkaido, Japan

Country:
Japan

Website Url:
http://www.carnabio.com

Total Employee:
51+

Status:
Active

Contact:
+81-78-302-7039

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache Global Site Tag


Similar Organizations

gynica-logo

Gynica

Gynica is a research and development company specializing in therapeutic cannabis research in the field of women's health.

Current Employees Featured

kohichiro-yoshino_image

Kohichiro Yoshino
Kohichiro Yoshino Founder, Owner, Chief Executive Officer & President @ Carna Biosciences
Founder, Owner, Chief Executive Officer & President
2003-04-01

Founder


kohichiro-yoshino_image

Kohichiro Yoshino

Acquisitions List

Date Company Article Price
2013-10-01 ProbeX ProbeX acquired by Carna Biosciences N/A

Investors List

dbj-capital_image

DBJ Capital

DBJ Capital investment in Seed Round - Carna Biosciences

Official Site Inspections

http://www.carnabio.com Semrush global rank: 4.33 M Semrush visits lastest month: 2.63 K

  • Host name: server30.extremeserv.net
  • IP address: 180.147.250.12
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "Carna Biosciences"

About Carna | About Us - About Us | Carna Biosciences, …

Apr 10, 2003 Carna Biosciences is a clinical-stage biopharmaceutical company founded in April 2003 in Kobe, Japan to discover and develop innovative therapies to treat serious unmet medical needs, focusing on small molecule …See details»

ABOUT US - CarnaBio USA, Inc.

[email protected] 209 West Central Street, Suite 307 Natick, MA 01760 USA TEL:+1-508-650-1244 / FAX:+1-508-650-1722 . NEWSLETTER. If you wish to receive a campaign mail or …See details»

Carna Biosciences, Inc. | LinkedIn

Carna Biosciences, Inc. | 489 followers on LinkedIn. Offering a broad range of high-quality kinase products and services to support your kinase inhibitor drug discovery | Carna Biosciences, a ...See details»

Carna Biosciences, Inc. Management Team | Org Chart

Carna Biosciences, a biotechnology company focusing on kinases as the important targets for the development of drugs to treat a variety of diseases, including cancer, inflammation, and …See details»

Carnabio USA Inc Company Profile | Natick, MA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for CARNABIO USA INC of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»

Carna Biosciences - Craft

Oct 29, 2024 Carna Biosciences has 5 employees across 2 locations and ¥1.63 b in annual revenue in FY 2023. See insights on Carna Biosciences including office locations, competitors, …See details»

Organization: Carna Biosciences - Cbonds.com

Organization name. Carna Biosciences Inc. Country name. Japan Country of registration-Industry. Miscellaneous Healthcare: Products and Services. Bond debt - ...See details»

Overseas Network - Carna Biosciences, Inc.

Carna Biosciences, Inc. BMA 3F, 1-5-5, Minatojima-Minamimachi, Chuo-Ku, Kobe Japan 650-0047 Phone: +81 78 302 7091 Fax: +81 78 302 7086See details»

CarnaBio USA, Inc. - VentureRadar

Carna Biosciences is a clinical-stage biopharmaceutical company founded in April 2003 in Kobe, Japan to discover and develop innovative therapies to... ... Find out ...See details»

Carnabio USA Company Profile - Office Locations, Competitors

Carnabio USA is a clinical-stage clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. It offers kinase proteins and other …See details»

Carna Biosciences, Inc. - 株式会社フィスコ

February 2016 Opened CarnaBio C-Lab as its U.S. research facility May 2016 Concluded a global, exclusive licensing agreement with U.S. Sierra Oncology, Inc. for its CDC7 kinase …See details»

カルナバイオサイエンス株式会社|KBIC 神戸医療産業都市ポータ …

創薬事業、創薬支援事業 事業概要. 創薬と創薬支援を同時に手掛ける創薬系バイオベンチャー カルナバイオサイエンス株式会社は、2003年、神戸において、日本オルガノン社からスピン …See details»

Carna Biosciences, Inc.

Mar 19, 2025 Carna Biosciences is a clinical-stage biopharmaceutical company founded in April 2003 in Kobe, Japan to discover and develop innovative therapies to treat serious unmet …See details»

Carna Biosciences CEO and Key Executive Team | Craft.co

Carna Biosciences's President and Chief Executive Officer, Representative Director is Kohichiro Yoshino. Other executives include Norio Aikawa, Head of Drug Discovery and Support …See details»

CarnaBio USA, Inc. - VentureRadar

Find out more about CarnaBio USA, Inc., Oncology, Life Sciences, Research Products and Scientific Services. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) …See details»

Management | About Us | Carna Biosciences, Inc.

President of CarnaBio USA, Inc. Ms. Yamamoto is the Chief Financial Officer and a member of the Board of Directors. She joined Carna Biosciences in 2004 after engaged in fund …See details»

CarnaBio USA Online Kinase Store – CarnaBio USA, Inc.

[email protected] 209 West Central Street, Suite 307 Natick, MA 01760 USA TEL:+1-508-650-1244 / FAX:+1-508-650-1722 . NEWSLETTER. If you wish to receive a campaign mail or …See details»

Carna Biosciences, Inc. (Carna Biosciences, Inc.) - 药物管线_专利_临 …

May 7, 2025 Abstract Introduction: Cell division cycle 7 (CDC7) is a highly conserved serine-threonine kinase that plays an important role in the initiation of DNA replication and cell cycle …See details»

Cancer treatments using inhibitors of CDK, a cell cycle regulator

Therapeutic potential of CDK2 inhibitors targeting HR+/HER2- breast cancer with CDK4/6 inhibitor resistance and CCNE1-amplified cancer Since the discovery of key regulators of the cell cycle …See details»

All Product Search - Carna Biosciences, Inc.

Mobility Shift Assay/IMAP™ assays directly monitor phosphorylation by measuring non-phosphorylated and phosphorylated substrate. IC50 is determined and/or inhibition ratio is …See details»

linkstock.net © 2022. All rights reserved